We evaluated four commercial transport systems with a standardized inoculum
of clinical isolates of N. gonorrhoeae (NG), and assessed survival after h
olding for up to 48 hours at both ambient and refrigeration temperatures. S
uspensions of clinical isolates of NG were standardized and adsorbed onto f
our transport swab types: Culturette EZ(TM) (Becton Dickinson [BD], Cockeys
ville, MD, USA); Cultureswab(TM) (Difco Laboratories, Detroit, MI, USA); Ve
nturi Transystem(TM) (Copan Italia, Bovezzo, Italy); and a recently modifie
d Starswab(TM) (Starplex Scientific, Etobicoke, ON). Swabs were plated to c
hocolate agar at 0, 6, 24, and 48 hours, and colonies counted. Each swab ty
pe was tested in quadruplicate with each NG strain for all time and tempera
ture variables. There was a marked reduction in NG CFUs after only 6 hours
incubation with each of the swabs tested. Survival was best using Venturi T
ransystem(TM) and Cultureswab(TM) transports (colony counts were reduced to
15.3% and 13.0%, respectively, at 6 hours) when compared with the Culturet
te EZ(TM) and Starswab(TM) (colony counts were reduced to 2.2% and 4.3%, re
spectively, at 6 hours). After the 24-hour holding period, 94% of the cultu
res from the Venturi Transystem(TM) were positive, 82% from the Cultureswab
(TM), 24% from the Starswab(TM); and 17% from the Culturette EZ(TM). After
48 hours, recovery dropped to 72%, 43%, 14%, and 0.04%, respectively. All o
f the systems tested had at least an 80% decrease in recovered colonies aft
er only 6 hours. Further studies are required to determine how poor transpo
rt conditions influence the number of positive cultures and what the public
health implications are. Of the swabs tested, Cultureswab(TM) and Venturi
Transystem(TM) were most acceptable. (C) 2000 Elsevier Science Inc. All rig
hts reserved.